ADAM17 has already been discussed as a valuable diagnostic and prognostic biomarker for colorectal cancer metastasis [68,83], early-stage ovarian cancer [84], and malignant CNS tumors [85]. This evidence concerns the gene ADAM17 and central nervous system cancer.